Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $652000.0.

  • Bio's Change in Account Payables rose 145238.1% to $652000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $50000.0, marking a year-over-year increase of 10563.06%. This contributed to the annual value of $482000.0 for FY2024, which is 428181.82% up from last year.
  • Latest data reveals that Bio reported Change in Account Payables of $652000.0 as of Q3 2025, which was up 145238.1% from -$2.3 million recorded in Q2 2025.
  • In the past 5 years, Bio's Change in Account Payables ranged from a high of $3.7 million in Q1 2023 and a low of -$3.7 million during Q2 2022
  • Over the past 5 years, Bio's median Change in Account Payables value was $258000.0 (recorded in 2021), while the average stood at $74210.5.
  • In the last 5 years, Bio's Change in Account Payables plummeted by 2896363.64% in 2022 and then surged by 145238.1% in 2025.
  • Bio's Change in Account Payables (Quarter) stood at $11000.0 in 2021, then tumbled by 28963.64% to -$3.2 million in 2022, then soared by 52.0% to -$1.5 million in 2023, then skyrocketed by 89.9% to -$154000.0 in 2024, then surged by 523.38% to $652000.0 in 2025.
  • Its last three reported values are $652000.0 in Q3 2025, -$2.3 million for Q2 2025, and $1.9 million during Q1 2025.